|
1
|
Watkins DA, Johnson CO, Colquhoun SM,
Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT,
Mayosi BM, Mensah GA, et al: Global, regional, and national burden
of rheumatic heart disease, 1990-2015. N Engl J Med. 377:713–722.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marijon E, Mirabel M, Celermajer DS and
Jouven X: Rheumatic heart disease. Lancet. 379:953–964. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guilherme L and Kalil J: Rheumatic fever
and rheumatic heart disease: Cellular mechanisms leading autoimmune
reactivity and disease. J Clin Immunol. 30:17–23. 2010. View Article : Google Scholar
|
|
4
|
Turkson J and Jove R: STAT proteins: Novel
molecular targets for cancer drug discovery. Oncogene.
19:6613–6626. 2000. View Article : Google Scholar
|
|
5
|
Gao W, McCormick J, Connolly M, Balogh E,
Veale DJ and Fearon U: Hypoxia and STAT3 signalling interactions
regulate pro-inflammatory pathways in rheumatoid arthritis. Ann
Rheum Dis. 74:1275–1283. 2015. View Article : Google Scholar
|
|
6
|
Liu J, Fei D, Xing J and Du J:
MicroRNA-29a inhibits proliferation and induces apoptosis in
rheumatoid arthritis fibroblast-like synoviocytes by repressing
STAT3. Biomed Pharmacother. 96:173–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee SH, Kim EK, Kwon JE, Lee JK, Lee D,
Kim SY, Seo HB, Na HS, Jung K, Kwok SK, et al: Ssu72 attenuates
autoimmune arthritis via targeting of STAT3 signaling and Th17
activation. Sci Rep. 7:55062017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye J, Guo R, Shi Y, Qi F, Guo C and Yang
L: miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4
axis in atherogenesis. Mediators Inflamm. 2016:80601822016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jahreis S, Kuhn S, Madaj AM, Bauer M and
Polte T: Mold metabolites drive rheumatoid arthritis in mice via
promotion of IFN-gamma- and IL-17-producing T cells. Food Chem
Toxicol. 109:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu XD, Zeng ZY, Gong DP, Wen JL and Huang
F: Potential involvement of S1PR1/STAT3 signaling pathway in
cardiac valve damage due to rheumatic heart disease. Biotech
Histochem. 94:398–403. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wen Y, Zeng Z, Gui C, Li L and Li W:
Changes in the expression of Th17 cell-associated cytokines in the
development of rheumatic heart disease. Cardiovasc Pathol.
24:382–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Teker E, Akadam-Teker AB, Ozturk O, Eronat
AP, Yalin K, Golcuk SE and Bugra Z: Association between the
interferon gamma 874 T/A polymorphism and the severity of valvular
damage in patients with rheumatic heart disease. Biochem Genet.
56:225–234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gorton D, Govan B, Olive C and Ketheesan
N: B- and T-cell responses in group a streptococcus M-protein- or
Peptide-induced experimental carditis. Infect Immun. 77:2177–2183.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friedrichs K, Gluba S, Eidtmann H and
Jonat W: Overexpression of p53 and prognosis in breast cancer.
Cancer. 72:3641–3647. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Purushothaman KR, Purushothaman M,
Turnbull IC, Adams DH, Anyanwu A, Krishnan P, Kini A, Sharma SK,
O'Connor WN and Moreno PR: Association of altered collagen content
and lysyl oxidase expression in degenerative mitral valve disease.
Cardiovasc Pathol. 29:11–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Q, Sun Y, Duan Y, Li B, Xia J, Yu S and
Zhang G: Comprehensive microRNA profiling reveals potential
augmentation of the IL1 pathway in rheumatic heart valve disease.
BMC Cardiovasc Disord. 18:532018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li N, Lian J, Zhao S, Zheng D, Yang X,
Huang X, Shi X, Sun L, Zhou Q, Shi H, et al: Detection of
differentially expressed MicroRNAs in rheumatic heart disease:
miR-1183 and miR-1299 as potential diagnostic biomarkers. Biomed
Res Int. 2015:5245192015.PubMed/NCBI
|
|
19
|
Dong H, Sun Y, Shan F, Sun Q and Yang B:
Down-regulation of miR-101 contributes to rheumatic heart disease
through up-regulating TLR2. Med Sci Monit. 21:1500–1506. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thai TH, Calado DP, Casola S, Ansel KM,
Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, et
al: Regulation of the germinal center response by microRNA-155.
Science. 316:604–608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Connell RM, Kahn D, Gibson WS, Round JL,
Scholz RL, Chaudhuri AA, Kahn ME, Rao DS and Baltimore D:
MicroRNA-155 promotes autoimmune inflammation by enhancing
inflammatory T cell development. Immunity. 33:607–619. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang C, Zhang C, Liu L, A X, Chen B, Li Y
and Du J: Macrophage-derived mir-155-containing exosomes suppress
fibroblast proliferation and promote fibroblast inflammation during
cardiac injury. Mol Ther. 25:192–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kriegsmann M, Randau TM, Gravius S,
Lisenko K, Altmann C, Arens N and Kriegsmann J: Expression of
miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded
synovial tissues of patients with rheumatoid arthritis and
osteoarthritis. Virchows Arch. 469:93–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Z, Liang K, Zou G, Chen X, Shi S,
Wang G, Zhang K, Li K and Zhai S: Inhibition of miR-155 attenuates
abdominal aortic aneurysm in mice by regulating macrophage-mediated
inflammation. Biosci Rep. 38:BSR201714322018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu J, Huang CX, Rao PP, Cao GQ, Zhang Y,
Zhou JP, Zhu LY, Liu MX and Zhang GG: MicroRNA-155 inhibition
attenuates endoplasmic reticulum stress-induced cardiomyocyte
apoptosis following myocardial infarction via reducing macrophage
inflammation. Eur J Pharmacol. 857:1724492019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He W, Huang H, Xie Q, Wang Z, Fan Y, Kong
B, Huang D and Xiao Y: MiR-155 knockout in fibroblasts improves
cardiac remodeling by targeting tumor protein p53-inducible nuclear
protein 1. J Cardiovasc Pharmacol Ther. 21:423–435. 2016.
View Article : Google Scholar
|
|
27
|
Kim SJ, Chen Z, Essani AB, Elshabrawy HA,
Volin MV, Volkov S, Swedler W, Arami S, Sweiss N and Shahrara S:
Identification of a novel toll-like receptor 7 endogenous ligand in
rheumatoid arthritis synovial fluid that can provoke arthritic
joint inflammation. Arthritis Rheumatol. 68:1099–1110. 2016.
|
|
28
|
Gollmann-Tepeköylü C, Pölzl L, Graber M,
Hirsch J, Nägele F, Lobenwein D, Hess MW, Blumer MJ, Kirchmair E,
Zipperle J, et al: miR-19a-3p containing exosomes improve function
of ischemic myocardium upon shock wave therapy. Cardiovasc Res. Aug
13–2019.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kikuta J, Iwai K, Saeki Y and Ishii M:
S1P-targeted therapy for elderly rheumatoid arthritis patients with
osteoporosis. Rheumatol Int. 31:967–969. 2011. View Article : Google Scholar
|
|
30
|
Choi HS, Kim KH, Jin S, Kim J, Yoo I, Pack
SP, Ha UH, Park TW, Choi SA, Yuk SH, et al: Decreased expression of
sphingosine-1-phosphate receptor 1 in the blood leukocyte of
rheumatoid arthritis patients. Immune Netw. 18:e392018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu H, Kortylewski M and Pardoll D:
Crosstalk between cancer and immune cells: Role of STAT3 in the
tumour microenvironment. Nat Rev Immunol. 7:41–51. 2007. View Article : Google Scholar
|
|
33
|
Xue XD, Huang JH and Wang HS: Angiotensin
II activates signal transducers and activators of transcription 3
via Rac1 in the atrial tissue in permanent atrial fibrillation
patients with rheumatic heart disease. Cell Biochem Biophys.
71:205–213. 2015. View Article : Google Scholar
|
|
34
|
Xue X, Liu Y, Wang Y, Meng M, Wang K, Zang
X, Zhao S, Sun X, Cui L, Pan L and Liu S: miR-21 and miR-155
promote non-small cell lung cancer progression by downregulating
SOCS1, SOCS6, and PTEN. Oncotarget. 7:84508–84519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma L, Xue HB, Wang F, Shu CM and Zhang JH:
MicroRNA-155 may be involved in the pathogenesis of atopic
dermatitis by modulating the differentiation and function of T
helper type 17 (Th17) cells. Clin Exp Immunol. 181:142–149. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pathak S, Grillo AR, Scarpa M, Brun P,
D'Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G, et al:
miR-155 modulates the inflammatory phenotype of intestinal
myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol
Med. 47:e1642015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan Y, Yang J, Xiang K, Tan Q and Guo Q:
Suppression of microRNA-155 attenuates neuropathic pain by
regulating SOCS1 signalling pathway. Neurochem Res. 40:550–560.
2015. View Article : Google Scholar
|
|
38
|
Yang Y, Yang L, Liang X and Zhu G:
MicroRNA-155 promotes atherosclerosis inflammation via targeting
SOCS1. Cell Physiol Biochem. 36:1371–1381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Scheller J, Chalaris A, Schmidt-Arras D
and Rose-John S: The pro- and anti-inflammatory properties of the
cytokine interleukin-6. Biochim Biophys Acta. 1813:878–888. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hodge DR, Hurt EM and Farrar WL: The role
of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer.
41:2502–2512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Narazaki M, Tanaka T and Kishimoto T: The
role and therapeutic targeting of IL-6 in rheumatoid arthritis.
Expert Rev Clin Immunol. 13:535–551. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tanaka T, Narazaki M and Kishimoto T: IL-6
in inflammation, immunity, and disease. Cold Spring Harb Perspect
Biol. 6:a0162952014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu N, Feng X, Wang W, Zhao X and Li X:
Paeonol protects against TNF-α-induced proliferation and cytokine
release of rheumatoid arthritis fibroblast-like synoviocytes by
upregulating FOXO3 through inhibition of miR-155 expression.
Inflamm Res. 66:603–610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Camporeale A and Poli V: IL-6, IL-17 and
STAT3: A holy trinity in auto-immunity? Front Biosci (Landmark Ed).
17:2306–2326. 2012. View
Article : Google Scholar
|
|
45
|
Bilik MZ, Kaplan I, Polat N, Akil MA,
Akyüz A, Acet H, Yüksel M, İnci Ü, Kayan F and Toprak N: Serum
levels of IL-17 and IL-23 in patients with rheumatic mitral
stenosis. Medicine (Baltimore). 95:e35622016. View Article : Google Scholar
|
|
46
|
Volin MV and Shahrara S: Role of TH-17
cells in rheumatic and other autoimmune diseases. Rheumatology
(Sunnyvale). 1:21692011. View Article : Google Scholar
|
|
47
|
Al-Saadany HM, Hussein MS, Gaber RA and
Zaytoun HA: Th-17 cells and serum IL-17 in rheumatoid arthritis
patients: Correlation with disease activity and severity. The
Egyptian Rheumatologist. 38:1–7. 2016. View Article : Google Scholar
|
|
48
|
Verschoor CP, Dorrington MG, Novakowski
KE, Kaiser J, Radford K, Nair P, Anipindi V, Kaushic C, Surette MG
and Bowdish DM: MicroRNA-155 is required for clearance of
Streptococcus pneumoniae from the nasopharynx. Infect Immun.
82:4824–4833. 2014. View Article : Google Scholar : PubMed/NCBI
|
